Consistent with this, we demonstrated that PDI-1 enhances NFAT activity in Jurkat T cells in a TCR- and PD-L1-dependent manner, thus providing a molecular mechanism by which PDI-1 enhances anti-tumor responses to NSCLC and melanoma in mice. This evidence concerns the gene PADI1 and non-small cell lung carcinoma.